AbCellera Biologics Inc. (ABCL)
ABCL Stock Price Chart
Explore AbCellera Biologics Inc. interactive price chart. Choose custom timeframes to analyze ABCL price movements and trends.
ABCL Company Profile
Discover essential business fundamentals and corporate details for AbCellera Biologics Inc. (ABCL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Dec 2020
Employees
596.00
Website
https://www.abcellera.comCEO
Carl Hansen
Description
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
ABCL Financial Timeline
Browse a chronological timeline of AbCellera Biologics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.17, while revenue estimate is $7.85m.
Earnings released on 11 May 2026
EPS came in at -$0.14 surpassing the estimated -$0.22 by +36.36%, while revenue for the quarter reached $8.32m , beating expectations by +53.63%.
Earnings released on 24 Feb 2026
EPS came in at -$0.03 surpassing the estimated -$0.18 by +83.33%, while revenue for the quarter reached $44.90m , beating expectations by +572.89%.
Earnings released on 6 Nov 2025
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $8.96m , beating expectations by +41.87%.
Earnings released on 7 Aug 2025
EPS came in at -$0.12 surpassing the estimated -$0.17 by +29.41%, while revenue for the quarter reached $17.08m , beating expectations by +168.63%.
Earnings released on 8 May 2025
EPS came in at -$0.15 surpassing the estimated -$0.17 by +11.76%, while revenue for the quarter reached $4.24m , missing expectations by -42.06%.
Earnings released on 27 Feb 2025
EPS came in at -$0.11 surpassing the estimated -$0.15 by +26.67%, while revenue for the quarter reached $5.05m , missing expectations by -33.37%.
Earnings released on 4 Nov 2024
EPS came in at -$0.17 falling short of the estimated -$0.14 by -21.43%, while revenue for the quarter reached $6.51m , missing expectations by -14.15%.
Earnings released on 6 Aug 2024
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%, while revenue for the quarter reached $7.32m , missing expectations by -27.85%.
Earnings released on 7 May 2024
EPS came in at -$0.14 surpassing the estimated -$0.16 by +12.50%, while revenue for the quarter reached $9.95m , missing expectations by -9.67%.
Earnings released on 20 Feb 2024
EPS came in at -$0.17 falling short of the estimated -$0.14 by -21.43%, while revenue for the quarter reached $9.18m , beating expectations by +3.37%.
Earnings released on 2 Nov 2023
EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $6.60m , missing expectations by -44.55%.
Earnings released on 3 Aug 2023
EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%, while revenue for the quarter reached $10.06m , missing expectations by -19.29%.
Earnings released on 4 May 2023
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $12.19m , beating expectations by +0.68%.
Earnings released on 21 Feb 2023
EPS came in at -$0.10 falling short of the estimated -$0.01 by -1.80k%, while revenue for the quarter reached $485.42m , beating expectations by +855.54%.
Earnings released on 8 Nov 2022
EPS came in at $0.08 surpassing the estimated $0.05 by +60.00%, while revenue for the quarter reached $101.38m , beating expectations by +35.25%.
Earnings released on 9 Aug 2022
EPS came in at -$0.02 falling short of the estimated -$0.02 by -28.45%, while revenue for the quarter reached $45.92m , missing expectations by -14.32%.
Earnings released on 10 May 2022
EPS came in at $0.54 surpassing the estimated $0.38 by +42.11%, while revenue for the quarter reached $316.58m , beating expectations by +44.06%.
Earnings released on 24 Feb 2022
EPS came in at $0.19 matching the estimated $0.19, while revenue for the quarter reached $139.33m , beating expectations by +14.16%.
Earnings released on 9 Nov 2021
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%, while revenue for the quarter reached $5.51m , missing expectations by -66.00%.
Earnings released on 12 Aug 2021
EPS came in at -$0.01 falling short of the estimated $0.09 by -111.11%, while revenue for the quarter reached $27.64m , meeting expectations.
ABCL Stock Performance
Access detailed ABCL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
